首頁 > 市場調查報告書 > 製藥

疼痛

北美醫用大麻市場預測至 2028 年 - COVID-19 影響和區域分析 - 按產品類型、應用和配銷通路

市場調查報告書

商品編碼

1375112

北美醫用大麻市場預測至 2028 年 - COVID-19 影響和區域分析 - 按產品類型、應用和配銷通路

North America Medical Marijuana Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product Type, Application, and Distribution Channel

出版日期: 2023年08月22日 | 出版商:

The Insight Partners | 英文 127 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

北美醫用大麻市場預計將從2022年的71.7017億美元成長到2028年的207.6041億美元。預計2022年至2028年的年複合成長率為19.4%。

醫用大麻產品的批准增加推動了北美醫用大麻市場的成長

大麻的藥用潛力吸引了各種研究人員和公司在醫療應用中使用大麻。例如，四氫大麻酚（THC）主要用於生產醫藥產品。美國食品藥物管理局 (FDA) 已批准基於 THC 的藥品，例如 Cesamet，其活性成分為 naboline，是一種具有類似 THC 結構的合成衍生產品。 Cesamet 用於治療接受化療的患者的噁心。當其他藥物無法控制噁心和嘔吐時，通常會開立 Cesamet。 FDA 也批准 Marinol 和 Syndros 在美國用於治療用途。 Marinol 和 Syndros 含有活性成分屈大麻酚 - 一種合成的 9-THC，被認為是大麻的精神活性成分。 Marinol 和 Syndros 藥物用於刺激消耗症候群患者的食慾，消耗症候群是愛滋病的適應症之一。同樣，各種基於大麻的產品已獲得批准或正在進行臨床試驗。例如，nabiximols (Sativex) 是在加拿大批准商業化的藥物。 Nabiximols 是一種大麻萃取物，用於治療與多發性硬化症相關的痙攣和神經性疼痛。它是由 THC 和其他大麻二酚 (CBD) 組合配製而成。 2020年2月，加拿大公司CanaQuest Medical Corp向加拿大衛生部申請核准Mentabinol的生產和商業化。 Mentabinol 是一種基於 THC 的產品，其批准申請已根據《大麻法》提交。 FDA 對上述大麻產品的批准增加正在推動醫用大麻市場的發展。

北美醫用大麻市場概況

北美醫用大麻市場分為美國、加拿大和墨西哥。據估計，醫用大麻市場在美國佔有最大佔有率。醫用大麻市場的成長可歸因於探索創新治療應用的研究和合作不斷增加、人們對醫用大麻的認知不斷提高以及該地區主要參與者的存在。此外，該地區不斷成長的老齡化人口也將有利於市場的成長。

北美醫用大麻市場收入及 2028 年預測（百萬美元）

北美醫用大麻市場細分

北美醫用大麻市場按產品類型、應用、配銷通路和國家細分。

根據產品類型，北美醫用大麻市場分為乾燥形式和萃取物形式。 2022 年，萃取物形式在北美醫用大麻市場中佔據更大佔有率。

根據應用，北美醫用大麻市場分為疼痛管理、妥瑞氏症、阿茲海默症、偏頭痛、憂鬱和焦慮、多發性硬化症、癌症等。 2022年，疼痛管理領域佔據北美醫用大麻市場的最大佔有率。

根據配銷通路，北美醫用大麻市場分為零售藥房、電子商務等。 2022年，零售藥局領域佔據北美醫用大麻市場的最大佔有率。

根據國家/地區，北美醫用大麻市場分為美國、加拿大和墨西哥。 2022年，美國主導北美醫用大麻市場。

阿芙莉亞公司； CanaQuest 醫療公司；頂篷 Growth 公司；翡翠健康治療公司； GW 製藥公司；馬里坎公司； Organigram 控股公司；帕納夏製藥工業有限公司；菲娜控股公司；和 VIVO Cannabis Inc 是北美醫用大麻市場的領先公司。

The medicinal potential of marijuana has attracted various researchers and companies to use marijuana in medical applications. For instance, tetrahydrocannabinol (THC) is predominantly used for producing medicinal products. The US Food and Drug Administration (FDA) has approved THC-based medicinal products such as Cesamet, which contains naboline as its active ingredient, is a synthetically derived product that has a structure like THC. Cesamet is prescribed for the treatment of nausea in patients receiving chemotherapy. Cesamet is generally prescribed when other medications cannot control nausea and vomiting. The FDA has also approved Marinol and Syndros for therapeutic uses in the US. Marinol and Syndros contain the active ingredient dronabinol-a synthetic 9-THC considered the psychoactive component of cannabis. Marinol and Syndros drugs are prescribed to stimulate appetite in patients with wasting syndrome, developed as one of the indications of AIDS. Similarly, various marijuana-based products have been approved or are in clinical trials. For instance, nabiximols (Sativex) is an approved drug commercialized in Canada. Nabiximols is a cannabis extract used to treat spasticity and neuropathic pain related to multiple sclerosis. It is formulated with a combination of THC and other cannabidiol (CBD). In February 2020, CanaQuest Medical Corp, a Canadian company, applied for the approval of the production and commercialization of Mentabinol to Health Canada. Mentabinol is a THC-based product, and its approval application has been filed under the Cannabis Act. The increase in approval of the above-mentioned marijuana-based products by the FDA is driving the medical marijuana market.

North America Medical Marijuana Market Overview

The North America medical marijuana market is segmented into the US, Canada, and Mexico. The medical marijuana market is estimated to have the largest share in the US. The growth of the medical marijuana market can be attributed to the increasing research and collaborations to explore innovative therapeutic applications, rising awareness regarding medical marijuana, and the presence of key players in the region. In addition, the growing aging population across the region will also favor the growth of the market.

North America Medical Marijuana Market Revenue and Forecast to 2028 (US$ Million)

North America Medical Marijuana Market Segmentation

The North America medical marijuana market is segmented into product type, application, distribution channel, and country.

Based on product type, the North America medical marijuana market is segmented into dried form and extract form. The extract form segment held a larger share of the North America medical marijuana market in 2022.

Based on application, the North America medical marijuana market is segmented into pain management, Tourette's, Alzheimer's disease, migraines, depression and anxiety, multiple sclerosis, cancer, and others. The pain management segment held the largest share of the North America medical marijuana market in 2022.

Based on distribution channel, the North America medical marijuana market is segmented into retail pharmacy, e-commerce, and others. The retail pharmacy segment held the largest share of the North America medical marijuana market in 2022.

Based on country, the North America medical marijuana market is segmented into the US, Canada, and Mexico. The US dominated the North America medical marijuana market in 2022.

Aphria, Inc.; CanaQuest Medical Corporation; Canopy Growth Corporation; Emerald Health Therapeutics Inc.; GW Pharmaceuticals; MARICANN INC.; Organigram Holdings Inc.; Panaxia Pharmaceutical Industries Ltd.; Phoena Holdings Inc.; and VIVO Cannabis Inc are the leading companies operating in the North America medical marijuana market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America medical marijuana market .
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in North America medical marijuana market , thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 North America Medical Marijuana Market - by Product
- 1.3.2 North America Medical Marijuana Market - by Application
- 1.3.3 North America Medical Marijuana Market - by Distribution Channel
- 1.3.4 North America Medical Marijuana Market - by Country

2. North America Medical Marijuana Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Medical Marijuana Market - Market Landscape

4.1 Overview
4.2 North America - PEST Analysis
4.3 Expert Opinion

5. North America Medical Marijuana Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Approvals of Medical Marijuana Products
- 5.1.2 Rising Acceptance of Medicinal Use of Marijuana in America
5.2 Market Restraints
- 5.2.1 Illegal Use of Cannabis as Street Drug and Misconceptions Regarding Marijuana
5.3 Market Opportunities
- 5.3.1 Increase in Job Opportunities in Marijuana Industry
5.4 Future Trends
- 5.4.1 Widespread Distribution of Medical Marijuana
5.5 Impact Analysis

6. Medical Marijuana Market - North America Analysis

6.1 North America Medical Marijuana Market Revenue Forecast and Analysis

7. North America Medical Marijuana Market Revenue and Forecast To 2028- by Product

7.1 Overview
7.2 North America Medical Marijuana Market Revenue Share, by Product (2021 and 2028)
7.3 Dried Form
- 7.3.1 Overview
- 7.3.2 Dried Form: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Extract Form
- 7.4.1 Overview
- 7.4.2 Extract Form: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)

8. North America Medical Marijuana Market Analysis - by Application

8.1 Overview
8.2 North America Medical Marijuana Market Revenue Share, by Application (2021 and 2028)
8.3 Pain Management
- 8.3.1 Overview
- 8.3.2 Pain Management: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Tourette's
- 8.4.1 Overview
- 8.4.2 Tourette's: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Alzheimer's Disease
- 8.5.1 Overview
- 8.5.2 Alzheimer's Disease: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Migraines
- 8.6.1 Overview
- 8.6.2 Migraines: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
8.7 Depression and Anxiety
- 8.7.1 Overview
- 8.7.2 Depression and Anxiety: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
8.8 Multiple Sclerosis
- 8.8.1 Overview
- 8.8.2 Multiple Sclerosis: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
8.9 Cancer
- 8.9.1 Overview
- 8.9.2 Cancer: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
8.10 Others
- 8.10.1 Overview
- 8.10.2 Others: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)

9. North America Medical Marijuana Market - by Distribution Channel

9.1 Overview
9.2 North America Medical Marijuana Market, by Distribution Channel (2021 and 2028)
9.3 Retail Pharmacy
- 9.3.1 Overview
- 9.3.2 Retail Pharmacy: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
9.4 E-Commerce
- 9.4.1 Overview
- 9.4.2 E-commerce: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Others
- 9.5.1 Overview
- 9.5.2 Others: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)

10. North America Medical Marijuana Market Revenue and Forecast to 2028 - Country Analysis

10.1 Overview
- 10.1.1 North America Medical Marijuana Market, by Country, 2021 & 2028 (%)
  - 10.1.1.1 US: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.1 US: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.2 US: Medical Marijuana Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.3 US: Medical Marijuana Market, by Application- Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.4 US: Medical Marijuana Market, Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
  - 10.1.1.2 Canada: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.1 Canada: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.2 Canada: Medical Marijuana Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.3 Canada: Medical Marijuana Market, by Application- Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.4 Canada: Medical Marijuana Market, Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
  - 10.1.1.3 Mexico: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.1 Mexico: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.2 Mexico: Medical Marijuana Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.3 Mexico: Medical Marijuana Market, by Application- Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.4 Mexico: Medical Marijuana Market, Distribution Channel - Revenue and Forecast to 2028 (US$ Million)

11. North America Medical Marijuana Market - Industry Landscape

11.1 Overview
11.2 Growth Strategies in the North America Medical Marijuana Market (%)
11.3 Organic Developments
- 11.3.1 Overview
11.4 Inorganic Developments
- 11.4.1 Overview

12. Company Profiles

12.1 VIVO Cannabis Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Panaxia Pharmaceutical Industries Ltd.
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Phoena Holdings Inc.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Emerald Health Therapeutics Inc.
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 MARICANN INC.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Aphria, Inc.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Canopy Growth Corporation
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 CanaQuest Medical Corporation
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 GW Pharmaceuticals
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Organigram Holdings Inc.
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms for North America Medical Marijuana Market

簡介目錄圖表

List Of Tables

Table 1. US: Medical Marijuana Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 2. US: Medical Marijuana Market, by Application - Revenue and Forecast to 2028 (US$ Million).
Table 3. US: Medical Marijuana Market, Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 4. Canada: Medical Marijuana Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 5. Canada: Medical Marijuana Market, by Application - Revenue and Forecast to 2028 (US$ Million).
Table 6. Canada: Medical Marijuana Market, Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 7. Mexico: Medical Marijuana Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 8. Mexico: Medical Marijuana Market, by Application - Revenue and Forecast to 2028 (US$ Million).
Table 9. Mexico: Medical Marijuana Market, Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 10. Organic Developments in the Medical Marijuana Market
Table 11. Inorganic Developments in the Medical Marijuana Market
Table 12. Glossary of Terms for North America Medical Marijuana Market

List Of Figures

Figure 1. North America Medical Marijuana Market Segmentation
Figure 2. North America Medical Marijuana Market, By Country
Figure 3. North America Medical Marijuana Market Overview
Figure 4. Extract Form Held Largest Share of Product Segment in Medical Marijuana Market
Figure 5. US to Show Remarkable Growth During Forecast Period
Figure 6. North America PEST Analysis
Figure 7. North America Medical Marijuana Market- Revenue Forecast and Analysis - 2020- 2028
Figure 8. North America Medical Marijuana Market Revenue Share, by Product (2021 and 2028)
Figure 9. Dried Form: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
Figure 10. Extract Form: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
Figure 11. North America Medical Marijuana Market Revenue Share, by Application (2021 and 2028)
Figure 12. Pain Management: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Tourette's: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. Alzheimer's Disease: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
Figure 15. Migraines: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. Depression and Anxiety: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. Multiple Sclerosis: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Cancer: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. Others: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. North America Medical Marijuana Market, by Distribution Channel (2021 and 2028)
Figure 21. Retail Pharmacy: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. E-commerce: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Others: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. North America Medical Marijuana Market, by Key Country - Revenue (2021) (US$ Million)
Figure 25. North America Medical Marijuana Market, by Country, 2021 & 2028 (%)
Figure 26. US: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Canada: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Mexico: North America Medical Marijuana Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. Growth Strategies in the North America Medical Marijuana Market (%)